Exact Mass: 227.1018348
Exact Mass Matches: 227.1018348
Found 187 metabolites which its exact mass value is equals to given mass value 227.1018348
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Flindersine
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.139 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.140
5-(4-methoxymethylfuran-2-yl)-1H-indole|5-[4-(methoxymethyl)furan-2-yl]indole|raputimonoindole C
tulobuterol
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents Tulobuterol (C-78 free base) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol is also a sympathomimetic agent used as a transdermal patch, and increases normal diaphragm muscle strength[1].
NPE_228.1019_12.4
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1112
N-Tosylbutylamine
CONFIDENCE standard compound; INTERNAL_ID 1337; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8734; ORIGINAL_PRECURSOR_SCAN_NO 8731 CONFIDENCE standard compound; INTERNAL_ID 1337; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8743; ORIGINAL_PRECURSOR_SCAN_NO 8740 CONFIDENCE standard compound; INTERNAL_ID 1337; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8774; ORIGINAL_PRECURSOR_SCAN_NO 8771 CONFIDENCE standard compound; INTERNAL_ID 1337; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8765; ORIGINAL_PRECURSOR_SCAN_NO 8763 CONFIDENCE standard compound; INTERNAL_ID 1337; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8779; ORIGINAL_PRECURSOR_SCAN_NO 8776
[1,2,4]Triazolo[4,3-a]quinolin-8-ol,1-ethyl-5-methyl-(9CI)
4-chloro-6-(4-methylpiperazin-1-yl)pyrimidin-5-amine
7-Methyl-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylic acid
3,6-DIHYDRO-1-METHYL-3-METHYLENE-SPIRO[3H-INDOLE-3,2-[2H]PYRAN]-2(1H)-ONE
Benzenesulfonamide,5-(1,1-dimethylethyl)-2-methyl-
METHYL 2-(5-MORPHOLINO-2H-1,2,3,4-TETRAAZOL-2-YL)ACETATE
Pyrido[2,3-b][1,6]naphthyridine, 7-acetyl-6,7,8,9-tetrahydro- (9CI)
Benzenesulfonamide,N-(1,1-dimethylethyl)-4-methyl-
N1-ETHYL-2-[(4-METHYLPHENYL)SULFONYL]ETHAN-1-AMINE
(NE)-N-[(4-phenylmethoxyphenyl)methylidene]hydroxylamine
6-Benzyl-6,7-dihydro-3H-pyrrolo[3,4-d]pyrimidin-4(5H)-one
4-Quinolinecarboxylicacid,2-cyclopropyl-6-methyl-(9CI)
4-ETHYL-6-METHOXY-1,2,3,4-TETRAHYDROISOQUINOLINEHYDROCHLORIDE
Tert-butyl 2-amino-4,5-dimethylthiophene-3-carboxyla
2-[[1-(4-chlorophenyl)-2-methylpropan-2-yl]amino]ethanol
1,2,3,4 tetrahydro-5-Methoxy-N- Methyl 2-napthalenamine HCl
3-(Dimethylamino)-1-(4-methylphenyl)propan-1-one Hydrochloride
2-[4-(2-CHLORO-4-NITROPHENYL)PIPERAZIN-1-YL]-ETHANOL
4-Chloro-6-(4-methylpiperazin-1-yl)pyrimidin-2-amine
4-[5-(1H-1,2,4-Triazol-1-Ylmethyl)-1H-1,2,4-Triazol-3-yl]Pyridine
1,5-Methano-1H-3-benzazepine, 2,3,4,5-tetrahydro-7-(trifluoromethyl)-, (1R,5S)-
CP-601927 is a selective α4β2 nicotinic acetylcholine receptor (nAChR) partial agonist (Ki=1.2 nM; EC50=2.6 μM). CP-601927 shows good brain penetration and antidepressant-like properties[1][2].
(18F)fluoroethyltyrosine
V - Various > V09 - Diagnostic radiopharmaceuticals > V09I - Tumour detection C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
9-Acetyl-2,3,4,9-tetrahydro-1H-carbazol-1-one
MS7972 is a small molecule that blocks human p53 and CREB binding protein association. MS7972 can almost completely block this BRD interaction at 50 μM[1].
2,3-Dihydroindol-1-yl-(1-methyl-4-pyrazolyl)methanone
3-methyl-N-(1H-pyrrol-2-ylmethylene)benzohydrazide
5-Ethyl-3-methyl-1,5-dihydro-4H-pyrazolo[4,3-C]quinolin-4-one
(1R,8S)-3-(trifluoromethyl)tricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-11-amine
(2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate
CP-601932
CP-601932 ((1S,5R)-CP-601927) is a high-affinity partial agonist at α3β4 nAChR (Ki=21?nM; EC50=~ 3?μM). CP-601932 has the same high-binding affinity at α4β2 nAChR (Ki=21?nM) and an order of magnitude lower affinity for α6 and α7 nAChR subtypes. CP-601932 selectively decreases ethanol but not sucrose consumption and operant self-administration following long-term exposure. CP-601932 can penetrate the CNS[1].